What is AppliedVR?
AppliedVR operates at the vanguard of the digital health revolution, specializing in the development of virtual reality (VR) platforms designed to mitigate chronic pain. By utilizing immersive technology, the company provides non-pharmacological alternatives that target the neurological pathways associated with pain perception. This innovative approach positions AppliedVR as a critical player in the evolving landscape of pain management, where the demand for scalable, effective, and non-addictive therapeutic solutions is rapidly increasing. The company's market position is bolstered by its integration into clinical workflows and its focus on rigorous, data-driven outcomes that meet the standards of modern medical practice.
How much funding has AppliedVR raised?
AppliedVR has raised a total of $71.3M across 4 funding rounds:
Angel/Seed
$6M
Debt
$350K
Series A
$29M
Series B
$36M
Angel/Seed (2016): $6M with participation from Techstars
Debt (2020): $350K led by PPP
Series A (2021): $29M supported by GSR Ventures, JAZZ Venture Partners, Cedars-Sinai, Sway Ventures, F-Prime Capital, and Magnetic Ventures
Series B (2021): $36M featuring F-Prime Capital Partners, Sway Ventures, SVB Ventures, and JAZZ Venture Partners
Key Investors in AppliedVR
F-Prime Capital Partners
A venture capital firm staffed by investors, engineers, and scientists dedicated to advancing healthcare and technology through strategic investments.
JAZZ Venture Partners
A firm focused on technologies that enhance human performance, investing at the intersection of healthcare, wellness, and consumer markets.
Sway Ventures
A venture capital firm that supports industry-disrupting founders from inception to exit, with a focus on transformative innovations across foundational industries.
What's next for AppliedVR?
With the recent influx of capital, AppliedVR is well-positioned to accelerate its commercial expansion and deepen its clinical research initiatives. The strategic focus will likely center on broadening the accessibility of its VR therapeutics across diverse healthcare systems and potentially expanding its product pipeline to address additional indications beyond chronic pain. As the digital therapeutics market matures, AppliedVR's ability to maintain its technological edge while navigating regulatory and reimbursement landscapes will be paramount. The company is expected to leverage its robust investor network to forge new partnerships, ensuring that its immersive treatment solutions become a standard component of comprehensive pain management strategies globally.
See full AppliedVR company page
